drug class semaglutide Weight-loss shown to reduce cocaine use in rats Ozempic vs Semaglutide : A
Description
Glucagon-like peptide 1 (GLP-1) based therapies have seen a meteoric rise in popularity (about 300%1 increased use between 2018-2023)

- - - A new Oxford meta-analysis (P04.009, EASO 2025) confirms what many clinicians have observed: stopping GLP-1 receptor agonists often leads to rapid and near-complete weight regain within 12 years

no rise in suicidality.

The GLP-1 Kitchen is a digital eCookbook designed for people taking GLP-1 medications and created as a practical resource that dietitians can recommend or

Our founder, obesity medicine p
